GSK pledges £1bn drive for infectious disease R&D
GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious diseases that mainly impact lower-income countries. The […]
GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious diseases that mainly impact lower-income countries. The […]
A cloud-based tuberculosis screening programme for rural communities in India, developed by UK company Feedback, is being supported by a cash injection from online retail […]
Only 54 of 166 assessed treatments have policies aiding use by low-income countries, says non-profit group The world’s biggest drugs makers have pressed on in […]
This updated fact sheet examines the key role played by the United States in the Global Fund, an independent, multilateral financing entity designed to raise […]
This fact sheet looks at the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global […]
Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots for other infectious diseases, and now plans […]
Date: August 23, 2021 Issue #: 1631 Summary: In a clinical trial conducted by the CDC’s Tuberculosis Trials Consortium in collaboration with the NIH-funded AIDS […]
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program […]
Tuberculosis is highly infectious and a global problem that Covid-19 has only made worse. Ironically, two legacies of our response to Covid-19 can give us […]
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea […]
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea […]
This fact sheet explains the U.S. government’s role in addressing the global tuberculosis (TB) epidemic, including the history of U.S. involvement and funding trends.
Amgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of Celgene’s psoriasis blockbuster Otezla last year would […]
A renewed interest in whether the BCG vaccine (for tuberculosis) could also have an application for COVID-19 has been on the rise, as evidenced by […]
Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing […]
We’ve seen the scientific community come together time and again throughout the COVID-19 pandemic, and we’re thrilled to have been part of a hackathon bringing […]
Copyright © 2024 | WordPress Theme by MH Themes